BDNF and Cognitive impairment: We also measured cognitive functioning (assessed by MoCA) following chronic substance consumption in plasma concentrations of NfL and BDNF in the SUD group using a one-way ANCOVA with “cognitive impairment” (non-cognitive impairment, mild cognitive impairment, and moderate/severe cognitive impairment) as a factor and age as a covariate.